State Budget FY26: Major Investments Propel New York’s Biomedical Research Forward
The Associated Medical Schools of New York (AMSNY) extends its sincere gratitude to Governor Kathy Hochul and the New York State Legislature for their unwavering support of biomedical research in the FY26 State Budget. These strategic investments ensure that New York remains at the forefront of scientific innovation, economic growth, and public health advancement.
Key Research Investments Include:
- $10 million reappropriated to the New York Fund for Innovation in Research and Scientific Talent (NYFIRST): This funding empowers medical schools to recruit and retain top-tier researchers, fostering groundbreaking discoveries and strengthening New York’s position in the global life sciences arena.
- $3.445 million restored to the Empire Clinical Research Investigator Program (ECRIP): ECRIP provides vital support for early-career physician-scientists, facilitating clinical research that directly benefits New Yorkers and enhances the state’s healthcare delivery system.
- $8.5 million allocated to the Spinal Cord Injury Research Program (NY SCIRP): SCIRP funds cutting-edge research aimed at developing treatments and cures for spinal cord injuries, improving quality of life for affected individuals and advancing neurological science.
These investments not only bolster New York’s research infrastructure but also stimulate job creation, attract federal funding, and drive economic development.
We thank our state leaders for their visionary commitment to biomedical research and look forward to continued collaboration in advancing health and science across the state. |